Thermal ablation with magnetic resonance–guided focused ultrasound surgery (MRgFUS) is a noninvasive technique for treating fibroids and cancer. New research from UC Davis shows that combining the technique with chemotherapy can allow complete destruction of tumors in mice.
MRgFUS combines an ultrasound beam that heats and destroys tissue with a magnetic resonance imaging to guide the beam and monitor the effects of treatment. The effectiveness of the treatment can be limited by the need to spare normal tissue or critical structures on the tumor margins, as well as the need to eliminate micrometastases.
In a new paper in The Journal of Clinical Investigation, Katherine W. Ferrara, distinguished professor of biomedical engineering at UC Davis, and colleagues report on a strategy that can destroy an entire tumor without thermal destruction of the tumor margin. Her group demonstrated a dramatic increase in the concentration of anti-cancer chemotherapy within several types of MRgFUS thermal ablation-treated tumors.
“MRgFUS is already FDA approved for the treatment of uterine fibroids and palliation of bone metastases. We hope to expand the indication for MRgFUS by supplementing it with chemotherapy,” said first author Andrew Wong, a graduate student with the UC Davis Physician Scientist Training Program.
Ferrara’s previous research has shown that ultrasound-induced mild hyperthermia can enhance the accumulation of tiny nanoparticles carrying anti-cancer drugs, but the accumulation is dependent on the type of tumor. Her group hypothesized that combining thermal ablation and chemotherapy could improve efficacy across multiple types of tumors.
The team used a variety of techniques including combined positron emission tomography/computed tomography (PET-CT), magnetic resonance imaging, autoradiography, and fluorescence imaging to track nanoparticles loaded with the chemotherapy drug doxorubicin in a mouse model of breast cancer.
They found that as the ultrasound damaged the tumor and induced a local immune response, nanoparticles accumulated in the tumor and the local drug concentration increased 50-fold. The high drug concentrations continued over several weeks, increasing total exposure of the tumor to the drug.
Ferrara’s research team found that the enhanced drug accumulation induced by MRgFUS resulted in improved survival and a consistent cure in their preclinical model of breast cancer, even when part of the tumor was left intact.
They also demonstrated that an effective cure could be achieved with a carefully designed protocol involving heat-activated nanoparticles, which, when gently heated by ultrasound, release their chemotherapeutic payload in the vasculature surrounding the tumor.
The Latest on: MRgFUS
via Google News
The Latest on: MRgFUS
- MRI-Guided Neurosurgical Ablation Market Size is Set to Hit $5.4 Bn upto 2027on May 25, 2020 at 4:35 am
The global MRI-Guided Neurosurgical Ablation Market size is expected to reach USD 5.4 billion by 2027, at a significant growth rate of 4.3% during the forecasted period 2020 to 2027. The research ...
- MR-Guided Focused Ultrasound for the Novel and Innovative Management of Osteoarthritic Knee Painon May 23, 2020 at 5:00 pm
All patients were eligible for TKA, and half of them were scheduled surgery and underwent MRgFUS treatment during waiting period. The others were scheduled only for MRgFUS treatment because they ...
- MR-Guided Focused Ultrasound for the Novel and Innovative Management of Osteoarthritic Knee Painon May 20, 2020 at 5:00 pm
This is the first report of clinical application of MRgFUS for knee OA. Real-time monitoring of the sonication area and temperature elevation enabled performance of safe and accurate treatment.
- Feasibility and safety of focused ultrasound-enabled liquid biopsy in the brain of a porcine modelon May 4, 2020 at 2:15 am
These pigs were divided into two groups. The first group consisted of 8 pigs that were used to optimize the design of a customized MRI-guided FUS (MRgFUS) system for BBB opening in pigs and ...
- Adenomyosis Awareness Month: Women describe 'agony' of living with barely-known conditionon April 28, 2020 at 11:00 pm
Ms Russell, who created Adenomyosis Awareness Month to highlight the condition, says more women need to be able to make a decision to have a family sooner rather than later - as targeted MRgFUS ...
- MRI Research Areason August 1, 2019 at 10:24 pm
MR-guided FUS Image-guided focused ultrasound technology, treatments, and bioeffects MR-guided Focused Ultrasound Surgery (MRgFUS) research develops novel image-guided treatment methods involving high ...
- Insightec: The Taiwanese Food and Drug Administration (TFDA) Approved Exablate Neuro for the Treatment of Essential Tremoron November 28, 2017 at 6:11 pm
INSIGHTEC, the leader in MR-guided Focused Ultrasound (MRgFUS) therapy, announced today that the Taiwanese Food and Drug Administration (TFDA) has approved its Exablate Neuro system for the treatment ...
- In Replyon April 30, 2015 at 3:35 pm
The factors determining its suitability for the treatment of fibroids are almost identical with those for MR-guided focused ultrasound surgery (MRgFUS). The success rates and the unincreased ...
- What Is Magnetic Resonance Guided Focused Ultrasound For Fibroids? - Dr. LeBlang (VIDEO)on January 31, 2015 at 12:50 am
Dr. LeBlang performed the first FDA-approved MRgFUS (Magnetic Resonance guided Focused Ultrasound) case in the U.S., the only non-invasive procedure for the treatment of uterine fibroids, and has, as ...
via Bing News